Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan;232(2):151-64.
doi: 10.1002/path.4266.

Mechanisms of age-related macular degeneration and therapeutic opportunities

Menno van Lookeren Campagne  1 , Jennifer LeCouter, Brian L Yaspan, Weilan Ye
Affiliations
Review

Mechanisms of age-related macular degeneration and therapeutic opportunities

Menno van Lookeren Campagne et al. J Pathol. 2014 Jan.

Abstract

As the age of the population increases in many nations, age-related degenerative diseases pose significant socioeconomic challenges. One of the key degenerative diseases that compromise quality of life is age-related macular degeneration (AMD). AMD is a multi-faceted condition that affects the central retina, which ultimately leads to blindness in millions of people worldwide. The pathophysiology and risk factors for AMD are complex, and the symptoms manifest in multiple related but distinct forms. The ability to develop effective treatments for AMD will depend on a thorough understanding of the underlying pathophysiology, risk factors, and driver molecular pathways, as well as the ability to develop useful animal models. This review provides an overview of the aforementioned aspects in AMD.

Keywords: age-related macular degeneration (AMD); best corrected visual acuity (BCVA); choroidal neovascularization (CNV); dry AMD; geographic atrophy (GA); neovascular AMD (NVAMD); retinal pigmented epithelial (RPE) cells; wet AMD.

PubMed Disclaimer